ARTICLE | Company News
Astellas seeks approval for EC905 in the Netherlands
March 28, 2012 12:59 AM UTC
Astellas Pharma Inc. (Tokyo:4503) submitted an MAA in the Netherlands for EC905 to treat lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia. Astellas said the submission ...